ZA201505006B - Compositions and methods for treating chronic inflammation and inflammatory diseases - Google Patents
Compositions and methods for treating chronic inflammation and inflammatory diseasesInfo
- Publication number
- ZA201505006B ZA201505006B ZA2015/05006A ZA201505006A ZA201505006B ZA 201505006 B ZA201505006 B ZA 201505006B ZA 2015/05006 A ZA2015/05006 A ZA 2015/05006A ZA 201505006 A ZA201505006 A ZA 201505006A ZA 201505006 B ZA201505006 B ZA 201505006B
- Authority
- ZA
- South Africa
- Prior art keywords
- compositions
- methods
- inflammatory diseases
- chronic inflammation
- treating chronic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361752309P | 2013-02-04 | 2013-02-04 | |
| PCT/EP2014/050627 WO2014117999A1 (en) | 2013-02-04 | 2014-01-14 | Compositions and methods for treating chronic inflammation and inflammatory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201505006B true ZA201505006B (en) | 2016-03-30 |
Family
ID=50150686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2015/05006A ZA201505006B (en) | 2013-02-04 | 2015-07-13 | Compositions and methods for treating chronic inflammation and inflammatory diseases |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP2950821A1 (enExample) |
| JP (1) | JP6474352B2 (enExample) |
| KR (1) | KR20150129664A (enExample) |
| CN (1) | CN105120900A (enExample) |
| AU (1) | AU2014211715B2 (enExample) |
| BR (1) | BR112015015870B1 (enExample) |
| CA (1) | CA2898017A1 (enExample) |
| HK (1) | HK1218621A1 (enExample) |
| IL (1) | IL239920A0 (enExample) |
| MX (1) | MX366317B (enExample) |
| RU (1) | RU2680801C2 (enExample) |
| SG (1) | SG11201505243PA (enExample) |
| WO (1) | WO2014117999A1 (enExample) |
| ZA (1) | ZA201505006B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
| US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US8895537B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating cardiovascular diseases |
| US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| EP3313519B1 (en) * | 2015-06-29 | 2023-05-31 | Children's Medical Center Corporation | Jak-stat inhibitors for the treatment of congenital myopathies |
| CN108283637A (zh) * | 2018-04-04 | 2018-07-17 | 无锡市儿童医院 | 辛伐他汀的应用 |
| WO2019195943A1 (en) * | 2018-04-13 | 2019-10-17 | Urban Juve Provisions Inc. | Cannabis root extract, method of manufacture, method of use |
| CN114051410A (zh) | 2019-04-30 | 2022-02-15 | 白雁生物技术公司 | 包含分离的线粒体为有效成分的预防或治疗肌炎的药物组合物 |
| CN114555103B (zh) * | 2019-06-03 | 2026-06-05 | 伊美诺路克斯国际公司 | 用于治疗疾病的天花疫苗和干细胞 |
| MX2022005168A (es) * | 2019-11-06 | 2022-06-08 | Smartech Topical Inc | Formulaciones topicas de inhibidores de la ciclooxigenasa y su uso. |
| RU2749857C1 (ru) * | 2019-12-23 | 2021-06-17 | Псарева Нелли Александровна | Способ борьбы со средним и наружным отитом |
| RU2752764C1 (ru) * | 2020-12-14 | 2021-08-03 | Общество с ограниченной ответственностью "Тривиум-ХХI" (ООО "Тривиум-ХХI") | Фармацевтическая композиция, обладающая противовоспалительным действием |
| AU2022248850A1 (en) | 2021-03-27 | 2023-11-09 | TRx Biosciences Limited | Compositions having improved bioavailability of therapeutics |
| RU2760220C1 (ru) * | 2021-06-02 | 2021-11-22 | Федеральное государственное бюджетное научное учреждение «Научно-исследовательский институт ревматологии имени В.А. Насоновой» (ФГБНУ НИИР им. В.А. Насоновой) | Способ определения клинически значимой усталости у больного ревматоидным артритом на фоне 5-летней терапии базисными противовоспалительными препаратами или базисными противовоспалительными препаратами в комплексе с генно-инженерными биологическими препаратами и/или психофармакотерапией и сопутствующего расстройства тревожно-депрессивного спектра |
| WO2025122472A1 (en) * | 2023-12-04 | 2025-06-12 | Primus Pharmaceuticals, Inc. | Emollient compositions comprising linoleic acid and conjugated linoleic acid and methods of use |
| WO2026132760A1 (en) * | 2024-12-19 | 2026-06-25 | IBUMIX Ltd | Lipophilic drug suspensions |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5143934A (en) * | 1990-11-21 | 1992-09-01 | A/S Dumex (Dumex Ltd.) | Method and composition for controlled delivery of biologically active agents |
| GB9613858D0 (en) * | 1996-07-02 | 1996-09-04 | Cortecs Ltd | Hydrophobic preparations |
| SI0999826T1 (en) * | 1997-07-29 | 2004-12-31 | Pharmacia & Upjohn Company | Self-emulsifying formulation for lipophilic compounds |
| US6063768A (en) | 1997-09-04 | 2000-05-16 | First; Eric R. | Application of botulinum toxin to the management of neurogenic inflammatory disorders |
| GB2331458B (en) * | 1997-11-21 | 2002-07-31 | Gursharan Singh Moonga | Solubilising systems for difficult pharmaceutical actives for preparing concentrated stable solutions for encapsulation into soft gelatine |
| US6267985B1 (en) | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
| US6294192B1 (en) | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6383471B1 (en) | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
| CA2369594A1 (en) * | 1999-05-07 | 2000-11-16 | Pharmasol Gmbh | Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same |
| KR20020011985A (ko) * | 1999-05-07 | 2002-02-09 | 파르마솔 게엠베하 | 액상 및 고체상 지질 혼합물에 기초한 지질입자들 및 그의제조방법 |
| WO2000076478A1 (en) * | 1999-06-14 | 2000-12-21 | Cosmo S.P.A. | Controlled release and taste masking oral pharmaceutical compositions |
| US6455067B1 (en) * | 2000-05-24 | 2002-09-24 | Sang-A Pharmaceutical Co., Ltd. | Transdermal patch for nonsteroidal antiinflammatory drug(s) |
| US20030105141A1 (en) * | 2001-04-17 | 2003-06-05 | Ping Gao | Finely self-emulsifiable pharmaceutical composition |
| JP2007500691A (ja) * | 2003-07-31 | 2007-01-18 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 抗炎症剤の分散性製剤 |
| AU2005309808A1 (en) * | 2004-11-24 | 2006-06-01 | Merck & Co., Inc. | Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide |
| US20060138059A1 (en) | 2004-12-28 | 2006-06-29 | Vair Larry L Jr | Corona-treated polypropylene liquid filtration media |
| AU2006240551A1 (en) * | 2005-04-28 | 2006-11-02 | Dsm Ip Assets B.V. | Pharmaceutical dosage forms comprising a lipid phase |
| US20070249725A1 (en) * | 2006-02-17 | 2007-10-25 | Hubbard David R | Pharmaceutical formulations of sympathetic antagonist for the treatment of chronic muscle pain |
| GB0704846D0 (en) * | 2007-03-13 | 2007-04-18 | Futura Medical Dev Ltd | Topical pharmaceutical formulation |
| ES2423793T3 (es) | 2008-05-26 | 2013-09-24 | Genfit | Compuestos agonistas de PPAR, preparación y usos para el tratamiento de la diabetes y/o dislipidemias |
| WO2012104655A2 (en) * | 2011-02-04 | 2012-08-09 | Biocopea Limited | Compostions and methods for treating chronic inflammation and inflammatory diseases |
-
2014
- 2014-01-14 CN CN201480006334.8A patent/CN105120900A/zh active Pending
- 2014-01-14 KR KR1020157020598A patent/KR20150129664A/ko not_active Withdrawn
- 2014-01-14 MX MX2015009058A patent/MX366317B/es active IP Right Grant
- 2014-01-14 AU AU2014211715A patent/AU2014211715B2/en active Active
- 2014-01-14 BR BR112015015870-6A patent/BR112015015870B1/pt active IP Right Grant
- 2014-01-14 WO PCT/EP2014/050627 patent/WO2014117999A1/en not_active Ceased
- 2014-01-14 EP EP14705479.5A patent/EP2950821A1/en not_active Withdrawn
- 2014-01-14 RU RU2015137659A patent/RU2680801C2/ru active IP Right Revival
- 2014-01-14 CA CA2898017A patent/CA2898017A1/en not_active Abandoned
- 2014-01-14 HK HK16106607.4A patent/HK1218621A1/zh unknown
- 2014-01-14 JP JP2015555630A patent/JP6474352B2/ja active Active
- 2014-01-14 SG SG11201505243PA patent/SG11201505243PA/en unknown
-
2015
- 2015-07-13 ZA ZA2015/05006A patent/ZA201505006B/en unknown
- 2015-07-14 IL IL239920A patent/IL239920A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016506941A (ja) | 2016-03-07 |
| AU2014211715B2 (en) | 2016-08-25 |
| MX2015009058A (es) | 2016-01-08 |
| CN105120900A (zh) | 2015-12-02 |
| HK1218621A1 (zh) | 2017-03-03 |
| EP2950821A1 (en) | 2015-12-09 |
| BR112015015870A8 (pt) | 2018-01-16 |
| BR112015015870A2 (pt) | 2017-07-11 |
| RU2015137659A (ru) | 2017-03-10 |
| WO2014117999A1 (en) | 2014-08-07 |
| AU2014211715A1 (en) | 2015-07-23 |
| CA2898017A1 (en) | 2014-08-07 |
| BR112015015870B1 (pt) | 2022-09-27 |
| KR20150129664A (ko) | 2015-11-20 |
| IL239920A0 (en) | 2015-08-31 |
| SG11201505243PA (en) | 2015-08-28 |
| MX366317B (es) | 2019-07-03 |
| JP6474352B2 (ja) | 2019-02-27 |
| RU2680801C2 (ru) | 2019-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL239920A0 (en) | Preparations containing solutions in solid state and their use for the treatment of chronic inflammation | |
| IL273815B (en) | Secondary vaccine particles for the treatment of inflammation | |
| ZA201305784B (en) | Compositions and methods for treating chronic inflammation and inflammatory diseases | |
| IL286759A (en) | Therapeutic methods and preparations | |
| IL241191A0 (en) | Local compositions and methods for treating local disorders | |
| ZA201505003B (en) | Solid solution compositions and use in chronic inflammation | |
| IL234829A0 (en) | Methods and preparations for treating inflammation | |
| IL239921A0 (en) | Preparations containing solutions in solid state and their use for the treatment of pain | |
| ZA201508186B (en) | Methods and compositions for wound healing | |
| EP3008167A4 (en) | Compositions and methods for treating metabolic disorders | |
| SG11201505457PA (en) | Compositions comprising 15-ohepa and methods of using the same | |
| EP2989123A4 (en) | METHODS AND COMPOSITIONS FOR TREATING COAGULATION DISORDERS | |
| EP3066472A4 (en) | Compositions and methods for detecting and/or treating inflammation | |
| IL245703A0 (en) | Methods and preparations for the treatment of amyloid deposits | |
| ZA201507724B (en) | The treatment of inflammatory disorders | |
| EP3019188A4 (en) | Methods for treatment of and prophylaxis against inflammatory disorders | |
| PL3319616T3 (pl) | Kompozycje pektynowe do zapobiegania wystąpieniu i leczenia chorób zapalnych | |
| EP2988737A4 (en) | Methods and compositions for treating diseases | |
| EP2968550A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANGIOGENESIS RELATED DISORDERS | |
| IL245613B (en) | Peptides for use in the treatment of inflammatory diseases that are not related to pathogenic factors | |
| GB201306411D0 (en) | Treatment of inflammatory conditions | |
| HK1192457A (en) | Compositions and methods for treating chronic inflammation and inflammatory diseases | |
| GB201319255D0 (en) | Therapeutic compositions and methods | |
| ZA201408732B (en) | Composition and methods for treating wounds |